Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
bristol-myers squibb
cancer immunotherapy
clinical trials
eli lilly
medicare
pain drug
president trump
startups
abbvie
What
bio
4
×
drug
4
×
roundup
alzheimer’s
companies
plan
prices
advantages
annual
approved
assessed
attention
bar
biotech
brings
communities
conference
different
digital
disease
epidemic
esmo
europe
expect
fail
fatty
fda
frenzied
gamble
gene
germany
growing
hosted
increases
investment
known
latest
led
liver
market
Language
unset
Current search:
investing
×
bio
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
